Recombinant Full Length Human IL5RA Protein
Cat.No. : | IL5RA-5687HF |
Product Overview : | Human IL5RA full-length ORF (NP_783852.1) recombinant protein without tag. |
- Specification
- Gene Information
- Related Products
Description : | The protein encoded by this gene is an interleukin 5 specific subunit of a heterodimeric cytokine receptor. The receptor is comprised of a ligand specific alpha subunit and a signal transducing beta subunit shared by the receptors for interleukin 3 (IL3), colony stimulating factor 2 (CSF2/GM-CSF), and interleukin 5 (IL5). The binding of this protein to IL5 depends on the beta subunit. The beta subunit is activated by the ligand binding, and is required for the biological activities of IL5. This protein has been found to interact with syndecan binding protein (syntenin), which is required for IL5 mediated activation of the transcription factor SOX4. Six alternatively spliced transcript variants encoding three distinct isoforms have been reported. [provided by RefSeq |
Source : | In Vitro Cell Free System |
Species : | Human |
Form : | Liquid |
Molecular Mass : | 38 kDa |
Protein Length : | 870 amino acids |
AA Sequence : | MIIVAHVLLILLGATEILQADLLPD EKISLLPPVNFTIKVTGLAQVLLQW KPNPDQEQRNVNLEYQVKINAPKED DYETRITESKCVTILHKGFSASVRT ILQNDHSLLASSWASAELHAPPGSP GTSIVNLTCTTNTTEDNYSRLRSYQ VSLHCTWLVGTDAPEDTQYFLYYRY GSWTEECQEYSKDTLGRNIACWFPR TFILSKGRDWLAVLVNGSSKHSAIR PFDQLFALHAIDQINPPLNVTAEIE GTRLSIQWEKPVSAFPIHCFDYEVK IHNTRNGYLQIEKLMTNAFISIIDD LSKYDVQVRAAVSSMCREAGLWSEW SQPIYVGFSR |
Applications : | Antibody Production Functional Study Compound Screening |
Notes : | Best use within three months from the date of receipt of this protein. |
Storage : | Store at -80 centigrade. Aliquot to avoid repeated freezing and thawing. |
Storage Buffer : | 25 mM Tris-HCl of pH8.0 containing 2% glycerol. |
Gene Name : | IL5RA interleukin 5 receptor, alpha [ Homo sapiens ] |
Official Symbol : | IL5RA |
Synonyms : | IL5RA; interleukin 5 receptor, alpha; IL5R; interleukin-5 receptor subunit alpha; CD125; CDw125; CD125 antigen; IL-5R subunit alpha; IL-5 receptor subunit alpha; interleukin 5 receptor type 3; interleukin-5 receptor alpha chain; HSIL5R3; MGC26560; |
Gene ID : | 3568 |
mRNA Refseq : | NM_000564 |
Protein Refseq : | NP_000555 |
MIM : | 147851 |
UniProt ID : | Q01344 |
Products Types
◆ Recombinant Protein | ||
IL5RA-251H | Recombinant Human IL5RA Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
Il5ra-1245M | Recombinant Mouse Il5ra Protein, MYC/DDK-tagged | +Inquiry |
IL5RA-2094H | Recombinant Human IL5RA Protein, MYC/DDK-tagged | +Inquiry |
IL5RA-241I | Active Recombinant Human IL5RA Protein | +Inquiry |
IL5RA-334H | Recombinant Human IL5RA Protein, His-tagged | +Inquiry |
◆ Lysates | ||
IL5RA-2060HCL | Recombinant Human IL5RA cell lysate | +Inquiry |
IL5RA-001MCL | Recombinant Mouse IL5RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionRecombinant IL5RA can be used to treat IL5-related diseases, such as severe asthma and eosinophilic diseases. It can reduce the frequency and severity of asthma attacks by blocking the signaling of interleukin 5.
Currently, recombinant IL5RA is mainly used to treat IL5-related diseases, such as severe asthma and eosinophilic diseases. For other diseases, the suitability of IL5RA is subject to further research and clinical trials.
During the use of IL5RA, the doctor may ask to check the patient's blood routine regularly to monitor changes in blood counts and related indicators. This helps to evaluate the efficacy of the treatment and the safety of the patient.
There is no clear evidence that long-term use of recombinant IL5RA causes dependence. For patients using IL5RA, it is best to treat and discontinue the drug according to the advice and guidance of their doctor.
IL5RA is generally administered by subcutaneous injection. The specific use method and dosage should be determined according to the doctor's recommendation and the specific situation of the patient.
Common side effects of recombinant IL5RA include pain at the injection site, redness and swelling at the injection site, cough, and sore throat. A small number of patients may experience allergic reactions or serious adverse reactions, so close monitoring of the patient's condition and signs is required when using.
Customer Reviews (3)
Write a reviewGood stability under different temperature and humidity conditions.
In the process of purification, the removal of impurities is good.
Chemical modifications, such as PEGylation or glycosylation, have little effect.
Ask a Question for All IL5RA Products
Required fields are marked with *
My Review for All IL5RA Products
Required fields are marked with *
Inquiry Basket